The enterohepatic circulation of bile acids plays a key role in a number of physiologically essential functions, including promoting hepatic bile flow and enhancing intestinal assimilation of fats and fat soluble vitamins (1) . In addition, bile acid excretion represents a major mechanism of cholesterol catabolism. The orderly movement of bile acids through the enterohepatic circulation is dependent upon an asymmetric array of vectorial transporters, which are located in the liver and intestine. A key member of this set of transporters is the apical sodium-dependent bile acid transporter (ASBT), 1 which is found on the apical surface of ileal enterocytes, renal proximal convoluted tubule cells, and large cholangiocytes (2) (3) (4) (5) (6) . In the ileum, ASBT plays a critical role in the intestinal reclamation of bile salts that are secreted by the liver. Complete disruption of this process leads to congenital primary bile acid malabsorption (7, 8) . Partial inhibition, by either ileal exclusion or pharmacologic blockade, leads to bile acid wasting and provides an important approach to the treatment of hypercholesterolemia and cholestasis (8 -12) . In contrast, to the well established physiological function of ASBT in the intestine, the importance of ASBT expression in renal and bile duct epithelial cells remains uncertain. No biliary or renal phenotype has been described in children with defects in the ASBT gene.
Regulation of ASBT expression is complex and has only been examined in recent descriptive studies. In the rat ileum, ASBT undergoes a biphasic pattern of regulation during normal development, with a fetal onset of expression, early post-natal down-regulation, followed by marked up-regulation at the time of weaning (3, 4, 13) . In contrast, renal expression of ASBT is constitutive during the same developmental stages. The basis of the ileal regulation appears to be both transcriptional and post-transcriptional. ASBT has a distinct pattern of expression along the longitudinal axis of the intestine with a restriction of its expression to the terminal 30% of the small bowel (14) . The bile acid responsiveness of the ASBT gene is a subject of unresolved controversy and may be species and experimental-condition specific (15) (16) (17) (18) (19) (20) . Intestinal inflammation appears to down-regulate ASBT expression, while glucocorticoid administration leads to up-regulation (21, 22) .
Given the overall importance of ASBT function in health and human disease, precise understanding of the molecular mechanisms of its regulation is of great importance. Exploitation of endogenous mechanisms of up-and down-regulation of this gene will provide novel approaches to the treatment of inflammatory bowel disease and hypercholesterolemia, respectively. Identification of key elements involved in directing ileal-specific expression of ASBT will lead to new ways to treat patients with short gut, where ileal function has been irreversibly lost. Similarly, identification of elements involved in the developmental regulation of ASBT expression will lead to new methods to care for premature infants, where intestinal function is immature. The human and rabbit ASBT 5Ј-flanking regions have been cloned (GenBank TM accession number AJ002005) (8, 23 ). Recent knock-out studies have shown that hepatocyte nuclear factor-1␣ (HNF-1␣) is critical for basal expression of ASBT (24) . The following investigations provide a further description of the transcriptional machinery of the ASBT gene.
EXPERIMENTAL PROCEDURES
Genomic Cloning and Organization-A rat P1 genomic library (25) was screened using the polymerase chain reaction (PCR) and ASBT cDNA-derived oligonucleotide primers (sense primer 5Ј-CGAAGGTGA-TTCCTGCCTAG-3Ј, antisense primer 5Ј-CAGCAACCCATAATTAGCA-CC-3Ј; Genome Systems, Inc., St. Louis MO). One of three positive clones was purified, digested with either HindIII or BamHI, and sub-cloned into a pZeRO TM -1 vector (InVitrogen, Carlsbad, CA). Ninety-six randomly selected subclones of each digest were spotted onto nitrocellulose and screened by Southern blotting using three different cDNA probes generated from ASBT clone BS32C2 (4). The insert in clone BS32C2 was released by digestion with KpnI and PstI and was subsequently digested with EcoRI and BamHI to yield 679-, 1206-, and 310-bp fragments which represented the 5Ј, middle, and 3Ј portions, respectively, of the ASBT cDNA. Selected positive genomic clones were sequenced on both strands using a series of synthetic oligonucleotides, AmpliTaq DNA polymerase, and an ABI 373A automated sequencing system (ABI, Foster City, CA) (26) . Oligonucleotide synthesis and DNA sequencing were performed at the William Keck Biotechnology Resource Laboratory at Yale University, New Haven, CT. Genomic sequence was compared with previously published cDNA sequence (Fig.  1) to determine the intron/exon organization of the rat ASBT gene (3) . DNA sequence analysis was performed using software of the Genetics Computer Group (Madison, WI). Mapping of the site of polyadenylation of the ASBT gene was determined by Northern blot analysis of rat ileal RNA using ApaLI/HindIII and SspI/ScaI fragments of ASBT genomic clone BSB2F (Fig. 1) .
Cell Lines and Culture Conditions-Caco-2 (HTB-37), HepG2 (HB-8065), MDCK (CCL-34) and HeLa-S3 (CCL-2.2) cells were obtained from the American Type Culture Collection (Rockville, MD). Caco-2, a human colon cancer cell line, was grown in Dulbecco's modified Eagle's medium supplemented with 4.5 g/liter glucose, 1 mM sodium pyruvate, 0.1 mg/ml human transferrin, and 10% fetal calf serum. The human liver tumor cell line HepG2 and the dog renal tubular epithelial cells MDCK were maintained in Eagle's minimum essential medium containing 2 mM L-glutamine, 1.5 g/liter sodium bicarbonate, 0.1 mM nonessential amino acids, 1.0 mM sodium pyruvate, and 10% fetal calf serum. HeLa-S3 cells were cultured in Ham's F12K medium with 2 mM L-glutamine, 1.5 g/liter sodium bicarbonate, and 10% fetal calf serum. All cells were grown at 37°C in 95% air and 5% CO 2 .
Primer Extension Analysis-Primer extension assays were carried out in order to identify the ASBT transcription initiation site within the 5Ј-flanking sequence (27) . The primer was a 27-mer oligonucleotide (5Ј-GCTAGTATGTCAGTTTCAAGAGGCTGC-3Ј) which hybridizes 180 bp upstream of the translational initiation codon (Fig. 2) . Fifteen g of total cellular RNA, extracted from rat ileum epithelial cells, was utilized as a template. The extension products were analyzed on a 6% polyacrylamide/urea gel and compared with the dideoxy sequencing reaction of plasmid BSB1C (Fig. 1) .
Plasmid Construction-To define cis elements involved in the regulation of ASBT expression, the rat ASBT 5Ј-flanking sequence and its subfragments were subcloned into a mammalian expression vector pGL3-Basic (Promega, Madison, WI), upstream of a firefly luciferase gene. A 3.1-kilobase (kb) BglII/NcoI fragment containing the largest (2.7 kb) rat genomic ASBT 5Ј-flanking region (ASBT 5Ј) was derived from clone BSB1C. The hybrid construct pGL3-ASBT5Ј/ Ϫ2685/ϩ384 (Fig. 2 , construct a) was generated by cloning this fragment into the pGL3-Basic plasmid in an orientation such that the sense strand DNA of the firefly luciferase gene was transcribed. Based on pGL3-ASBT5Ј/
Ϫ2685/ϩ384
, ASBT 5Ј-deletion/ hybrid constructs were prepared, in order to localize transcriptional cis elements. The construct pGL3-ASBT5Ј/ Ϫ2685/Ϫ830 (Fig. 2, construct b ) was made by insertion of an upstream 1.9-kb sequence of the ASBT 5Ј region into the polylinker of the pGL3-Basic vector. pGL3-ASBT5Ј/ Ϫ829/ϩ384 (Fig.  2, construct c) , was prepared by insertion of a downstream XhoI/NcoI 1.2-kb fragment containing 0.8-kb of the ASBT 5Ј sequence.
Based upon the transcription initiation sites that were found by primer extension assay, two DNA fragments with 496 bp (P2) and 327 bp (P3), respectively, were generated by PCR, using BSB1C plasmid as a template. Constructs were sequenced to confirm the veracity of the amplification process. P2 and P3 contain the sequences flanking both sides of, and including, a TATA box, the transcription initiation sites and two AP-1 cis elements (Fig. 2, constructs d and e). These two fragments were then subcloned into XhoI/HindIII-nicked pGL3-Basic, forming the constructs pGL3-ASBT5Ј/ Ϫ378/ϩ118 and pGL3-ASBT5Ј/ Ϫ208/ϩ118
, respectively. In order to precisely localize the cis element in ASBT 5Ј-flanking region, six DNA oligonucleotides (C1-C6) of 54 -55 bp corresponding to different portions of P3 sequence (Fig. 2, P3 subfragments) were synthesized and tested for the trans-acting factor binding activity by band-shift assay. Additional 15-bp oligonucleotides were used to further define the cis-and trans-acting elements.
Site-directed PCR Mutagenesis of ASBT 5Ј Sequence-The site-directed point mutagenesis of ASBT 5Ј-flanking region was performed by a QuikChange TM Site-directed Mutagenesis Kit (Stratagene, La Jolla, CA), targeting to two AP-1 cis elements contained in P3 DNA fragment corresponding to the ASBT 5Ј-flanking region, positioned from Ϫ208 to ϩ118 (28, 29) . DNA oligonucleotide primers, P3mu-1 and P3mu-2 were synthesized, with sequences of 5Ј-GCCAATAAATGATTGATTATAAC-TTTCTGTCTTGG-3Ј and 5Ј-GGACTTTTTATATTTATTATTTGTGC-3Ј, respectively, which contained mutations as shown by underlined nucleotides (A 7 G, T 7 C). The third primer P3mu-3 is the combination of the sequences and mutations of the primers P3mu-1 and P3mu-2. The PCR products, pGL3-ASBT5Ј/P3M1, pGL3-ASBT5Ј/P3M2, and pGL3-ASBT5Ј/P3M3, were examined for their sizes by electrophoresis, and the produced point mutations contained within the P3 fragment were confirmed by DNA sequencing.
Transient Transfection and Luciferase Analysis of Cells-Confluent cells (5 ϫ 10 6 /plate) were harvested and resuspended in 700 l of phosphate-buffered saline containing 4 g of the ASBT5Ј/luciferase hybrid plasmid constructs and 0.1 g of a quantitation control plasmid containing a thymidine kinase promoter-driven Renilla luciferase gene (Promega, Madison, WI). Transfection was accomplished by electroporation (30) at 0.22 kV and 0.95 F ϫ 1,000 (Bio-Rad). After electroporation, the cells were resuspended in culture medium and returned to a plate for culturing for 40 h before dual luciferase assays (Promega, Madison, WI) using standard techniques as recommended by the manufacturer (31) . The effect of c-Jun on promoter activity was assessed by co-transfection of a cytomegalovirus promoter driven c-Jun expression construct (32) .
Preparation of Cell Nuclear Extracts and Band Shift Assays-Nuclear extracts were prepared from confluent cells or rat ileal mucosal scrapings using previously described techniques (33) . Nuclear extracts were aliquoted into vials, quick-frozen, and stored at Ϫ80°C. Five micrograms of nuclear proteins were incubated, with the appropriate 32 P-labeled ASBT 5Ј-flanking DNA fragments or oligonucleotides (34, 35) . For band supershift analysis, specific antibodies were added together with the DNA probe and protein samples. Following digestion with 1 l (127 units/l, Life Technologies, Inc.) of DNase I at 37°C for 30 min, samples were subjected to electrophoresis in a 7% native polyacrylamide gel. The rat small intestine was divided into four equal segments (proximal jejunum, distal jejunum, proximal ileum, and distal ileum) for analysis of the regional specificity in the rat small intestine. Rat terminal ileum (distal 25% of small intestine) was obtained from 10 (pre-weaning) and 28 (post-weaning)-day-old rats in order to assess developmental stage specificity.
Ultraviolet (UV) Cross-linking Assays-DNA-protein binding reactions were carried out as described above, using 2 ϫ 10 5 cpm of 32 Plabeled DNA fragments or oligonucleotides and 5 g of nuclear protein per reaction. Following incubation at 37°C for 1 h, 1 l of DNase I (127 units/l) was added to the reaction mixture in order to digest the unbound DNA fragments. Reaction mixtures were transferred to wells of a 96-well microtiter plate, and irradiated on ice by UV light at 1,200 microjoules for 7 min, using a UV-Stratalinker chamber apparatus (Stratagene, La Jolla, CA). The samples were analyzed by electrophoresis through a 7% SDS-polyacrylamide gel.
RESULTS
Genomic Cloning and Organization-Transcriptional analysis required elucidation of the genomic organization of the ASBT gene and cloning/sequencing of its 5Ј-flanking region. The ASBT gene extends over ϳ17 kb and consists of six exons and five introns ( Fig. 1 and Table I ). Primer extension analysis using ileal total RNA identified two potential sites of transcription initiation, which were 323 (genomic ASBT bp ϭ Ϫ68) and 255 (genomic ASBT bp ϭ 0) bp from the translation start site (Figs. 2 and 3). A TATA box is located between these two sites (Ϫ12 to Ϫ9). Approximately 2800 bp of the 5Ј-flanking sequence have been cloned, sequenced, and utilized for the transcriptional studies described here (GenBank TM accession number AF285154). The sizes of the intronic regions of the ASBT gene were confirmed by a series of PCR reactions utilizing rat genomic DNA (data not shown). The entire 3.1 kb of 3Ј-untranslated sequence was found in a single intron (GenBank TM Accession number U07183). The first potential conserved polyadenylation signal was found 3116 bp from the cDNA stop codon (36) . Two additional polyadenylation signals were found in the immediate 3Ј region of the ASBT gene. Northern blot analysis of ileal total RNA mapped the polyadenylation signal to the first of these three potential sites (Fig. 4) .
ASBT 5Ј-Flanking DNA Possesses Transcriptional Promoter
Activity-A luciferase reporter assay system was utilized in order to investigate the promoter function of the ASBT 5Ј-flanking region. ASBT5Ј/luciferase hybrid constructs were made using a pGL3-Basic vector (Promega) which contains a firefly luciferase coding region as a reporter gene. Caco-2 cells were chosen as transfectants for reporter gene assays since they are an intestinally derived cell line and support sodiumdependent bile acid transport activity (37) . They also express ASBT transcripts (data not shown) and thus have the necessary factors for ASBT transcription. Cells transfected with pGL3-Basic and pGL3-SV40 were employed as negative and positive controls, respectively, with the latter containing an SV40 promoter-driven firefly luciferase gene. Calibration of transfection efficiency was achieved by co-transfection of cells with pRL-TK plasmids that express Ranilla luciferase. To test whether ASBT5Ј has promoter activity, reporter gene assays were carried out initially using the full-length ASBT5Ј construct pGL3-ASBT5Ј/ Ϫ2684/ϩ384 (Fig. 2, construct a) . Results demonstrated that the cloned genomic ASBT5Ј sequence possessed significant transcriptional activity, which was 61% of that of SV40 promoter, as reflected by luciferase activities (Fig.  5, panel A) . The transcriptional activity of the downstream 0.8-kb ASBT 5Ј sequence (pGL3-ASBT5Ј/ Ϫ829/ϩ384 ) was 22% of that of the full-length 5Ј sequence, however, still 30 times higher than that of the control construct pGL3-Basic which contains no promoter sequence. No luciferase activity was detected in cells transfected with pGL3-Basic as well as pGL3-ASBT5Ј/ Ϫ2685/Ϫ830 (data not shown) compared with the background measurement, indicating that the upstream 1.9-kb sequence has no transcriptional activity.
A
208-bp Region Preceding the Downstream Transcription Initiation Site Demonstrates Major
Promoter Activity-Since a number of intestinal promoters have key regulatory elements near the transcription initiation start site, the proximal promoter of ASBT was carefully characterized. Two ASBT5Ј-related DNA fragments P2 and P3 with 496 bp (ASBT5Ј nucleotide positions Ϫ378 to ϩ118) and 327 bp (ASBT 5Ј nucleotide positions Ϫ208 to ϩ118), respectively, were generated by PCR and sequenced. Both fragments contain the transcription initiation sites and TATA box, and are part of the downstream 0.8-kb 5Ј sequence which showed transcriptional activity (Fig.  2, construct c) . P2 and P3 possess 40 and 34%, respectively, of the transcriptional activity of the full-length 5Ј sequence (Fig.  5, panel A) .
Nuclear Trans-acting Proteins Specifically Bind to ASBT 5Ј Sequences-To test the hypothesis that trans-acting factors exist that can bind to cis-element(s) of ASBT5Ј, a band-shift assay was carried out initially with nuclear proteins extracted from Caco-2 cells and 32 P-labeled ASBT 5Ј sequences, which included P2 and P3. Four DNA-ASBT-binding protein (ABP1-ABP4) complexes were detected as shown in the panel B of Fig.  5 . Furthermore, a cross-linking assay was performed with radiolabeled P3 as the probe to measure the molecular weights of the ABPs found by the band-shift analysis. As shown in panel C of Fig. 5 , four protein bands were detected with apparent molecular weights of 100,000, 73,000, 70,000, and 43,000.
To determine ABPs DNA binding specificity, the unlabeled P2 was tested for the ability to compete for ABPs binding to the 32 P-labeled P2 sustrate. Preincubation of Caco-2 nuclear proteins with an unlabeled 1.2-kb fragment of the ASBT 5Ј-flanking region (Ϫ829 to ϩ384) followed by addition of the radiolabeled P2 substrate, resulted in a concentration-dependent reduction in the formation of the DNA-protein complexes (Fig.  5, panel D) . Binding of ABP2 and ABP4 were markedly affected, with lesser but substantial effect observed for ABP1 and ABP3. Addition of up to 2 nM nonspecific competitor, a 1.2-kb XbaI fragment of pGL3-Basic plasmid had no effect on the (Fig. 5, panel D) , indicating that the DNAprotein interactions are specific. Further evidence of the specificity of the interaction is the fact that no nuclear proteins were bound by a radiolabeled XbaI fragment of the pGL3-Basic plasmid (Fig. 5, panel B, Control) . Furthermore, the DNAABPs binding characteristics were examined. DNase I pretreatment of radiolabeled P3 inhibited the formation of ABPs-DNA complexes (data not shown) excluding the possibility of nonspecific [ 32 P]dCTP binding to ABPs. It was also shown that pretreatment of the nuclear preparation with either proteinase K or SDS could abolish the binding to P3 (data not shown), indicating that the binding activity of ABPs is proteinase K and SDS sensitive. These results confirm that the complexes detected by the band-shift assay are composed of DNA and FIG. 2. Schematic diagrams of ASBT 5 constructs. Construct a contains the full-length 2.7-kb ASBT 5Ј sequence upstream of the reporter gene. Positions of the important sites are shown, including those identified in further experiments; Primer PE3 indicates sequence utilized for primer extension assay. Construct b is a 1.9-kb upstream ASBT 5Ј sequence restricted by BglII/XhoI and corresponding to the region from Ϫ2685 to Ϫ830. Construct c is a 1.2-kb fragment and covers the region of Ϫ829 to ϩ384 obtained by digestion with XhoI/NcoI. Constructs d (P2) and e (P3) are PCR synthesized and correspond to the 5Ј sequences of Ϫ378 to ϩ118 and Ϫ208 to ϩ118, respectively. P3 subfragments C1-C6 are in vitro synthesized. Each subfragment contains 54 -55 base pairs corresponding to different portions of P3 sequence. All these ASBT 5Ј fragments, except C1-C6, were subcloned into the polylinker of the expression vector pGL3-Basic, which contains a firefly luciferase gene downstream of the polylinker.
polypeptides.
Identification of 5Ј cis-Elements Involved in ASBT Expression-To determine further the cis-element(s) of ASBT5Ј, six DNA fragments (Fig. 2, C1-C6 ) of 54-55 bp corresponding to different portions of P3 sequence were synthesized, radiolabeled, and incubated with the nuclear extracts for band-shift assay. Interestingly, we found that one of the ABPs, ABP2, only bound to C4 and C5, but failed to bind to other fragments (Fig.  6, panel A) , suggesting that these two fragments may contain the cis-element(s) which interact with the trans-acting factor.
Further analysis of the cis-element(s) existing within P3 was carried out using MacVector software and transcription factor data bases. P3 contained two AP-1 cis-elements (ASBT5Ј nucleotide positions Ϫ30 to Ϫ24 and ϩ20 to ϩ26, respectively). The proximal site (upstream ϭ uAP-1) was located immediately upstream of the TATA box and the lower transcription initiation site. The distal AP-1 site (downstream ϭ dAP-1) was located 18 nucleotides downstream of the lower transcription site (Fig. 2, construct a) . Furthermore, the upper (5Ј-sided) AP-1 cis-element was contained in C4 and the lower (3Ј-sided) one contained in C5 fragment (Fig. 2, P3 subfragments) . This finding was consistent with the result obtained in the bandshift assay, where we showed that ABP2 only bound to C4 and C5 and not the rest of the P3-related subfragments tested, as described above (Fig. 6, panel A) .
These findings strongly suggested that AP-1 played a key role in the transcriptional regulation of the ASBT gene. This was confirmed by examination of plasmid constructs containing the AP-1-mutated P3, which were generated by a QuikChange TM site-directed mutagenesis kit (Stratagene, La Jolla, CA). pGL3-ASBT5Ј/P3M1 and pGL3-ASBT5Ј/P3M2 contained point-mutated upstream and downstream AP-1 element, respectively, each with other elements in normal sequence. pGL3-ASBT5Ј/P3M3 had the mutations of both pGL3-ASBT5Ј/P3M1 and pGL3-ASBT5Ј/P3M2. Results of the reporter gene assays, as shown in panel B of Fig. 6 , demonstrated that in comparison with the normal P3 construct, mutation of the upper AP-1 element (M1) resulted in a 10-fold decrease in luciferase gene transcription. Mutations of both AP-1 sites (M3) lead to almost complete abrogation of promoter activity, compared with the basic construct. In contrast, mutation of the lower AP-1 element (M2) alone caused a negligible decline in the luciferase activity (Fig. 6, panel B) . These results further support the finding that the upper AP-1 cis-element, which locates upstream of the lower transcription initiation site within the 5Ј-region, is responsible, at least in part, for ASBT gene transcription.
c-Jun Is a Component of ABP2 in Caco-2 Cells-The AP-1 transcriptional complex is composed of at least two major factors, c-Jun and c-Fos (38) . AP-1 functions as a dimer in the form of Jun/Fos or Jun/Jun, depending on individual target genes. Because we demonstrated that an AP-1 cis-element controlled ASBT expression, supershift assays with monoclonal antibodies against c-Fos and c-Jun (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) were used to examine whether these transcription factors existed in ABPs identified by band-shift assay. As shown in panel C of Fig. 6 , a supershifted band (upper arrow) was formed by addition to the reaction mixture of the c-Jun monoclonal antibody, but was not detected in the presence of c-Fos monoclonal antibody. As the supershifted complex was formed, the ABP2 band disappeared at the original position (panel C of Fig. 6, lower arrow) , confirming that ABP2 contains c-Jun protein. This result is consistent with the findings obtained in the band-shift assay, which showed ABP2 only bound to AP-1-containing fragments C4 and C5 (Fig. 6, panel  A) . Electrophoretic mobility shift assay analysis using 15-bp oligonucleotides that included either the downstream (d-AP-1) or upstream (u-AP-1) AP-1 sites demonstrated that the ABP2 was the result of binding to the upstream AP-1 site (Fig. 6,  panel D) . The difference in electrophoretic mobility of the complexes formed with u-AP1 and d-AP1 suggests that there are significant differences in the proteins that bind to these two different elements.
To further determine the relationship between ABP2 and AP-1-binding protein, competitive band-shift assays were conducted with in vitro synthesized specific competitors, 15-bp fragments containing a normal or mutated AP-1 consensus sequence. Caco-2 cell nuclear proteins were preincubated with the unlabeled competitor, followed by addition of the radiolabeled normal P3 fragment as the probe. The band-shift assay demonstrated that ABP2 band was missing only after addition of the unlabeled 15-bp fragments containing the normal AP-1 element sequence, indicating a specific interaction between ABP2 and AP-1 cis-element (Fig. 6, panel E) . The mutated AP-1
FIG. 3. Identification of transcription initiation sites within the ASBT 5 region.
To determine the transcription initiation site within the ASBT 5Ј region, a primer (PE3) was synthesized, with the sequence of 5Ј-GCTAGTATGTCAGTTTCAAGAGGCTGC-3Ј (located 180 bp upstream of the translation initiator ATG, Fig. 2, construct a) . As shown in the figure, two sites (arrow) were found which correspond to nucleotide positions 323 and 255 bp upstream of the translation initiator ATG. sequences failed to compete off ABP2 band (Fig. 6, panel E) . In addition, there was no band shift observed using the mutated AP-1 element and Caco-2 nuclear extracts (data not shown). Taken together, these observations demonstrate that in Caco-2 cells ABP2 is a c-Jun-like, AP-1-binding factor or complex, which is involved in ASBT gene expression by interaction with AP-1 cis-elements contained within the downstream portion of the 5Ј sequence. Transient co-transfection of Caco-2 cells with c-jun and pGL3-ASBT/ Ϫ208/ϩ118 led to enhancement of luciferase activity (Fig. 6, panel B) .
ASBT 5Ј-Directed Gene Expression Is Cell Line-specific-Cell lines have been utilized as a surrogate to analyze organ-specific expression of genes. This approach is especially useful for transient transfection analysis. As a preliminary stage of investigation, RT-PCR analysis was performed on several standard cell lines in order to identify candidates that expressed the ASBT mRNA. Previously described degenerate oligonucleotide primers that spanned intron 1 were utilized (3). Appropriate sized products (data not shown) were identified in MDCK and Caco-2 cells, while HepG2 and HeLa cells were negative. We then determined whether there was a correlation between cell line expression of ASBT and its ability to support promoter activity. In the experiments, Caco-2, HeLa-S3, HepG2, and MDCK cells were transfected with the pGL3-ASBT5Ј/ Ϫ208/ϩ118 hybrid plasmid construct, followed by luciferase assays. Luciferase activity could only be detected in the Caco-2 cells (Fig. 6,  panel A) . These findings indicate that there is not an exact correlation between the ability of cell line to express ASBT and its ability to support ASBT promoter function. Co-transfection of MDCK cells with both a c-jun expression construct and pGL3-ASBT5Ј/ Ϫ208/ϩ118 resulted in markedly enhanced luciferase activities that approximated that seen in Caco-2 cells.
In order to further understand the correlation between ASBT mRNA expression and transcriptional activity, ASBT5Ј DNA binding activity was assessed. ABPs-DNA interactions were assessed by band-shift assay using the radiolabeled ASBT 5Ј-sequence and nuclear proteins from the ASBT ϩ and ASBT Ϫ cells. Caco-2 nuclear proteins were used as control. Interestingly, the results demonstrated that ABP2, the AP-1-binding protein, was absent in HeLa and MDCK cells, whereas it was present in HepG2 cells (Fig. 7, panel B) .
AP-1 Expression Correlates with Region and Developmental Stage-specific Expression of ASBT in the Rat Small Intestine-
Two important aspects of the regulation of ASBT expression are region specificity and ontogeny. In order to assess the role of AP-1 in this aspect of regulation, gel-shift and Western blotting studies were performed using different segments of adult rat intestine and terminal ileum from pre-and postweaning rat intestine. The pattern of four DNA-binding proteins observed by gel shift analysis with nuclear extracts from rat distal ileal (DI) mucosal scrapings was the same as that observed with Caco-2 nuclear extracts (Fig. 8, panel A) . Interestingly, ABP2 was missing in the mucosa of the jejunum (PJ and DJ) and only trace amounts were detected in the proximal ileum (PI). Supershift analysis revealed the presence of both c-Jun and c-Fos in the DNA-protein complexes derived from rat distal ileal mucosal scrapings (Fig. 8, panel B) . Western blot analysis revealed that c-Jun and c-Fos protein expression was restricted to the distal ileum (Fig. 8, panel A) . ASBT expression along the longitudinal axis of the small intestine correlated with the presence of ABP2, c-Jun, and c-Fos (Fig. 8, panel A) .
Other members of the AP-1 family of proteins, with the exception of FosB were not correlated with the expression of ASBT (Table II) . The ontogenic expression of ASBT correlated with the expression of AP-1. ABP2, c-Fos, c-Jun, and ASBT were detected in terminal ileum from 28-day-old rats, but not from 10-day-old rats ( Fig. 9) . Additional Western blot analysis of rat nuclear extracts revealed significantly greater expression of HNF-1 in PI and DI compared with PJ and DJ and marked enhancement of expression in 28-day-old rats compared with 10-day-old rats (data not shown).
DISCUSSION
The complex nature of intestinal gene expression necessitates a highly regulated system. The intestinal mucosa undergoes marked and perpetual proliferation that requires careful control in order to maintain normal physiology. Intestinal gene expression is also highly regulated along the crypt to villus and longitudinal axes and in the specific cell types that make up the intestinal mucosa. As such, the transcriptional regulation of genes in the intestine is of great importance, and significant advances have been made in beginning to understand these complex systems (39 -43) . ASBT is an important candidate gene for analysis, as it provides information relevant to specific aspects of intestinal gene expression as well as to the enterohepatic circulation of bile acids. The tissue-specificity of ASBT expression is somewhat unusual in that it is found in intestine, bile duct epithelium, and kidney. In addition, ASBT has a distinctive pattern of regulation along the longitudinal axis of the intestine, with expression restricted to the terminal ileum (14, 44, 45) . The ileal lipid-binding protein has a similar pattern of expression along the longitudinal axis of the intestine (46) . Transgenic mouse analysis of the ileal lipid-binding protein promoter indicates that this pattern of expression is controlled by elements in the proximal promoter, although the specific molecular mechanisms underlying that regulation are unknown.
The rat ASBT gene was cloned from a P1 library and analysis of its genomic organization revealed that it consists of six reporter assay system (Promega) was used to examine transcriptional activities of rat ASBT 5Ј sequences. All activities were normalized to thymidine kinase promoter driven Renilla luciferase. The results show that cells transfected with the construct containing the full-length 2.7-kb ASBT 5Ј sequence express the highest luciferase activity, ϳ60% of that induced by SV40 promoter. The promoter activities of the downstream 1.2 kb region, P2 and P3 are 22, 40, and 34%, respectively, of that of the full-length 5Ј sequence. B, band-shift assays were carried out with 5 g of Caco-2 cell nuclear extract and 2 ϫ 10 5 cpm of radiolabeled ASBT 5Ј sequences as indicated on the top of each lane. Four DNA-binding proteins, named as ABP1-4, were detected. The control reveals that there are no bands seen when a 1.2-kb XbaI fragment of pGL3 is utilized. C, to assess the molecular weights of ABPs, cross-linking assays were conducted with 5 g of Caco-2 nuclear proteins and 2 ϫ 10 5 cpm of 32 Plabeled ASBT 5Ј sequences, as indicated on the top of each lane. Four protein bands with molecular weights of 100,000, 73,000, 70,000, and 43,000, respectively, were detected, which bound to all the sequences tested. D, to examine ABPs-DNA binding specificity, 5 g of nuclear proteins from Caco-2 cells were preincubated with the unlabeled specific competitor (1.2 kb fragment from Ϫ829 to ϩ384) or nonspecific competitor (a 1.2-kb pGL3-basic vector sequence), followed by addition of the radiolabeled P2 fragments, at the concentrations as shown on the top of the lanes. Binding of ABP2 and ABP4 were markedly affected, with lesser but substantial effects observed for ABP1 and ABP3. There was no inhibition of binding by the nonspecific competitor, indicating that the ABPs DNA binding activity is specific.
exons. This genomic organization is nearly identical to that observed in humans and rabbits (8, 23) . In all three species the second through fifth exons are nearly identical in size. The 5Ј-and 3Ј-untranslated regions in the three species are variable, with the 3Ј-untranslated region in excess of 2.6 kb in all three. In rats and rabbits the first intron is large, 5700 and 7556 bp, respectively. Analysis of the 3Ј-untranslated region of the rat ASBT gene reveals three potential polyadenylation sites, which are all at least 3118 bp from the translation stop codon. Multiple AUUUA elements, which have been associated with mRNA instability, are present in this long 3Ј-untranslated RNA (47) .
Analysis of the mechanisms underlying the transcriptional regulation of ASBT expression were performed using a cloned 3.1-kb DNA fragment containing 2.7 kb of ASBT 5Ј genomic sequence. Primer extension analysis identified two transcription FIG. 6 . Localization of cis-elements within the ASBT 5 region. A, to further localize the nuclear protein-binding sites within P3 sequence, P3 subfragments were in vitro synthesized, each of which contained 54 -55 bp and was incubated with the nuclear extracts, followed by the band-shift assay. C4 and C5 bound to all the ABPs; however, other subfragments failed to bind to ABP1 and ABP2, indicating that these two proteins bound to a cis-element which only exists in C4 and C5. B, point mutations of the upstream (M1) or both (M3) AP-1 elements resulted in inhibition of ASBT 5Ј-directed luciferase gene expression, as compared with the positive control (P3). Point mutations of the downstream (M2) AP-1 sequence had no significant effect on the gene expression. Co-expression of c-Jun with P3 lead to significant enhancement of luciferase activity. C, a supershifted band (upper arrow) was detected with c-Jun, but not c-Fos, monoclonal antibody. Correspondingly, the ABP2 band disappeared at the original position (lower arrow), indicating that the supershift band contains the DNA-binding protein that is recognized by c-Jun antibody. D, electrophoretic mobility shift assay analysis of a 15-bp oligonucleotide centered on the upstream AP-1 site (u-AP-1) revealed a single species that had the same electrophoretic mobility as ABP2. Similarly, the downstream AP-1 (d-AP-1) generated a band similar to ABP3. E, Caco-2 nuclear proteins were preincubated with a 15-bp fragment containing a normal (AP-1) or mutated AP-1 (AP-1 mu) consensus sequence, followed by addition of the 32 P-labeled P3 probe and band-shift analysis. Normal, but not mutated, AP-1 sequence can compete off P3 ABP2 binding activity, indicating that ABP2 binds to the AP-1 cis-element.
initiation sites in the rat ASBT 5Ј-region. This finding is consistent with RNase protection assays which identified two different sized copies of rat ASBT transcripts (48) . These two sites in the rat are significantly closer together than the two sites that have been identified in humans (8, 49) . The 2.7-kb ASBT 5Ј-flanking sequence exhibited very strong promoter activity, ϳ60% of that of SV40 promoter. The downstream 0.8-kb fragment expresses moderate promoter activity, indicating the 1.9-kb fragment may contain enhancer element(s). Basic promoter activity was found within a 208-bp region immediately upstream of the lower transcription initiation site.
This minimal promoter contains two transcription initiation sites and a TATA box between the two sites (Fig. 2, construct e) , A, band-shift assays were carried out with radiolabeled P3 as a probe and nuclear extracts from different quartiles of the rat small intestine (PJ, proximal jejunum; DJ, distal jejunum; PI, proximal ileum; C, Caco-2 (positive control)). ABP2 is only observed primarily in the distal ileum. Faint signal is detected in PI. B, Western blot analysis was performed using ileal homogenates or membrane vesicles. c-Jun (78 kDa), c-Fos (75 kDa), and ASBT (48 kDa) were detected primarily in the DI segment of rat intestine, although a small amount of the three proteins could be found in the PI segment. These proteins were absent in the PJ and DJ segments. Equivalent loading is demonstrated by signal intensity for the 45-kDa actin protein. C, supershift analysis of rat ileal mucosal nuclear extracts demonstrates the presence of both c-Jun and c-Fos. A phosphotyrosine antibody was used as a negative control.
suggesting a potential core sequence for the origin of ASBT transcription. This is supported by the finding that this sequence, starting from Ϫ208, is highly conserved in the ASBT 5Ј-region of different species including rat, human, and rabbit, with an average homology of 88% (Fig. 10) . Electrophoretic mobility shift assays revealed that four nuclear proteins ABP1-ABP4 bound this minimal promoter sequence in a specific fashion as determined by competition studies. The trans-acting binding activities, especially for ABP1 and ABP2, were further mapped to the P3-related subfragments C4 and C5, by bandshift assay with in vitro synthesized oligonucleotides. Both C4 and C5 contain an AP-1 consensus sequence. These sites were absolutely conserved in the proximal promoters in humans and rabbits. Furthermore, an in vitro synthesized 15-bp fragment containing a normal AP-1 consensus sequence was able to directly bind to ABP2 and efficiently competed off the protein binding activity of P3; whereas, a 15-bp sequence containing a mutated AP-1 element failed to have these abilities. These results indicate that AP-1 is the ABP2-binding cis-element. This was further strengthened by detection of a supershifted ABP2 with a c-Jun monoclonal antibody. Rat ileal mucosa contained proteins that supershifted with both c-Fos and c-Jun antibodies. A number of potential explanations exist to explain the differential expression of c-Fos. Caco-2 cells derived from a human epithelial tumor cell line, while rat ileal mucosal scrapings are derived from a number of different cell types. The functional significance of the difference in expression in c-Fos will need to be assessed. The enhancement of ASBT promoter activity, in both Caco-2 and MDCK cells, by co-expression of c-Jun strongly supports the hypothesis that AP-1 plays an important role in the transcriptional regulation of ASBT.
AP-1-binding proteins are composed of a dimer containing Jun, Fos, or other activating transcription factor proteins depending on the individual targeting gene (38) . Given the diversity of potential elements that may bind to the AP-1 site, a wide variety of regulatory phenomenon may be mediated by AP-1. There is a growing body of evidence that suggests that AP-1 may play an important role in intestinal gene expression. In the rat intestinal cell line, IEC-6, dexamethasone lead to an increase in c-jun mRNA and increased AP-1 DNA binding (50) . Enterocyte-like differentiation of the human colon cancer cell line, Caco-2, has been associated with an increase in c-Jun, JunD, c-Fos, and Fra-2 gene products (51) . Intestinal cell growth as mediated by either L-glutamine or polyamines appears to be mediated at least in part through AP-1 (52, 53) . After surgically induced intestinal ischemia and subsequent reperfusion, AP-1 activity is markedly up-regulated via c-fos (54) . Finally, the intestinal specific expression of the neurotensin/neuromedin N gene may be dependent upon at AP-1/CRElike motif in the proximal promoter of this gene (55) .
One potential regulatory role for AP-1 may be the control of tissue and region-specific expression. Analysis of the expression of AP-1 trans-acting factors in the developing mouse and chicken support this hypothesis (56 -58) . For example, JunB expression appears to be restricted to the developing mouse skin and intestine (56) . Our studies demonstrate both regionand developmental stage-specific expression of c-Jun and c-Fos in the rat small intestine. The correlation of the expression of these AP-1 elements with ASBT DNA-binding protein patterns on gel shift analysis and the expression of ASBT strongly suggests that AP-1 is involved in determining region and developmental stage specificity. This is a major advance, since transgenic mouse studies have indicated that cis-acting factors may impart specific patterns of expression in the intestine, although the specific cis-and trans-acting elements have not been determined (46, 59 -61) .
ASBT 5Ј-directed gene expression is cell line specific, although the in vitro transcriptional activity cannot be completely reconciled with the presence of ASBT transcripts in specific cell lines. Clearly, Caco-2 cells contain all of the necessary transcriptional machinery for ASBT expression. In contrast, HeLa cells do not generate ASBT transcripts and do not express ABP2. On the other hand MDCK cells contain the necessary machinery to generate ASBT transcripts, but do not support promoter activity. The absence of ABP2 in MDCK cells may indicate that a different set of binding proteins mediate ASBT expression in kidney and/or in dogs. It is especially important that c-Jun expression in MDCK cells endows this cell line with the capacity to support ASBT promoter activity. Finally, the ABP2 detected in HepG2 cells appears to bind to DNA but does not trans-activate ASBT expression. This indicates that HepG2 cells contain an AP-1 complex with a different composition. Liver cells have a distinct but related sodiumdependent bile acid transporter system whose transcriptional regulation is not mediated through AP-1 (62) . Further experiments are needed to characterize the biochemical properties of the two ABP2s found in Caco-2 and HepG2 cell lines, respectively.
Recent knock-out studies indicate that HNF-1␣ also plays a key role in the transcriptional regulation of ASBT (24) . The knock-out mice have increased fecal and urinary excretion of bile salts, which is coupled with reduced ileal expression of ASBT protein and mRNA. Analysis of the human ASBT promoter revealed a functional hepatocyte nuclear factor-1␣-binding site. This site is highly conserved and is immediately proximal to the conserved AP-1-binding site (see Fig. 10 ). These findings strongly suggest that the complex patterns of expression of ASBT may be controlled by combinatorial regulation utilizing both hepatocyte nuclear factor-1␣ and AP-1 (63, 64) . This is supported by the fact that the expression of the HNF-1 protein during intestinal development and along the longitudinal axis of the intestine is similar to the pattern seen for ASBT.
In summary, the rat ASBT gene has been cloned and its promoter analyzed by luciferase reporter gene assays and studies on DNA/nuclear protein interactions. A 208-bp region of the proximal promoter appears to be sufficient to impart basic promoter activity and cell line specificity. These effects appear FIG. 9 . Analysis of ASBT DNA/protein interactions during post-natal development of the rat small intestine. A, Western blot analysis was performed using ileal homogenates or membrane vesicles. c-Jun (78 kDa), c-Fos (75 kDa), and ASBT (48 kDa) were detected from 28 but not 10-day-old rat ileum. Equivalent loading is demonstrated by signal intensity for the 45-kDa actin protein. B, band-shift assays were carried out with radiolabeled P3 as a probe and nuclear extracts from the terminal ileum of 10-(pre-weaning) and 28 (post-weaning)-day-old rats. ABP2 is only observed in the 28-day-old rat ileum. Caco-2 cell nuclear extract was used as a positive control (c).
to be mediated in large part through AP-1. Mutations of the AP-1 cis-elements lead to suppression of ASBT directed gene expression. The trans-acting factors involved in ASBT expression include at least four nuclear proteins ABP1-4, among which ABP2 has been identified as an AP-1 element binding both c-Jun and c-Fos. Formation of the complex ABP2 appears to be correlated with cell line specificity, and region-and developmental stage-specific expression in the rat small intestine. Further analysis of this system will provide important insights into intestinal gene regulation and many aspects of the enterohepatic circulation of bile acids.
